Popular weight-loss drugs Ozempic and Wegovy may slow biological aging By calming inflammation and reducing excess fat, semaglutide may postpone several molecular signs of aging, pointing to the potential of GLP1 receptor agonists to help prevent agerelated diseases Date: July 14, 2026 Source: University of California - San Diego Summary: Researchers found that semaglutide, the active ingredient in Ozempic and Wegovy, slowed biological aging markers in adults with HIV, marking the first clinical evidence that the drug may influence human aging
Another protein OSTZF1 enhances the expression of ROS-scavenging enzymes and genes responsible for redox homeostasis which helps in modulating abiotic stress resistance [164]
From there, it's no surprise that the EC3 spread like wildfire
The two therapies target different metabolic stages: Lipo B addresses liver function and fat handling, while semaglutide modulates appetite signaling and glucose control
Timing Best time to take Post-workout is ideal for training daysyour muscles are like sponges ready to absorb nutrients
It has been observed to reduce HbA1c levels, a key marker of long-term blood glucose control